Sponsorship Alliance Partner News

News from Our Sponsorship Alliance Partners

May 2022


Owner of Arkansas Derby Winner Named Horse After the Life-Changing Accuray CyberKnife® Radiation Therapy Technology Used to Treat His Cancer

When Al Gold, the owner of the Arkansas Derby winner Cyberknife, received a diagnosis of prostate cancer, he was determined to find a potential cure for his disease while minimizing the impact of treatment on his daily life. Mr. Gold's research led him to a referral for treatment using the Accuray Incorporated CyberKnife® System. His real-world experience and positive results compelled him to name a racehorse after the company's one-of-a-kind robotic technology.

Click to Learn More

Zap Surgical

Baptist Health South Florida to Acquire ZAP-X Gyroscopic Radiosurgery Platform

Novel vault-free, cobalt-free SRS system looks bring unparalleled neurosurgical care, complement the center’s broad portfolio of radiation delivery technologies.

Click to Learn More

April 2022


Geisinger Debuts $80M Cancer Center Expansion

Geisinger held a ribbon cutting March 23 on an $80 million expansion to the cancer center at Geisinger Wyoming Valley Medical Center in Wilkes-Barre, Pa.

Click to Learn More


First Toxicity Results from SCIMITAR Prospective Phase II Trial Signal Favorable Toxicity Profile of Post-Prostatectomy Stereotactic Body Radiotherapy (SBRT) for Prostate Cancer

Post-hoc Analysis Highlights Reduction in Gastrointestinal (GI) Toxicity with MRIdian® MRI-guided SBRT Compared to CT-guided SBRT, with No MRI-guided SBRT Patients Experiencing Grade 3 Genitourinary (GU) or Grade ≥2 Gastrointestinal Toxicity.

Click to Learn More


RefleXion Raises $80 Million to Broaden Cancer Treatment Options

"The steadfast belief in RefleXion’s vision by our investor syndicate gives us the runway to drive hard and fast toward developing our platform for indications where radiotherapy was previously considered palliative only,” said Todd Powell, president and CEO of RefleXion.

Click to Learn More

RefleXion Dedicates The Sam Gambhir Memorial Learning Center After First Advisor

RefleXion is honored to dedicate its Clinician Learning Center and to rename it in honor of the late Sam Gambhir, MD, PhD. As the first scientific advisor to RefleXion, his impact and legacy will be long remembered.

Click to Learn More

Zap Surgical

Vive la France! Unicancer, representing 19 French cancer centers, selects the vault-free, cobalt-free ZAP-X as its preferred SRS platform.

Unicancer, a leading academic promoter of oncology clinical trials and medical equipment purchasing cooperative has selected ZAP-X as their SRS technology-of-choice for their member institutions.

Click to Learn More

ZAP announces multi-system order with Apollo Hospitals in India.

World-renowned hospital network to become the first provider in South Asia to offer ZAP-X Gyroscopic Radiosurgery, the latest advance in world-class radiosurgery.

Click to Learn More


HyperArc High-Definition Radiotherapy Achieves High Scores for Quality, Ease of Planning, and Workflow Efficiency

A recent study(1) comparing VMAT with HyperArc gave the latter high scores for quality, ease of planning, and workflow efficiency. The report covers nearly 700 patients treated over a 30-month period with single-isocenter SRS delivered on a Varian Edge® system and addressing some 2,000 targets. Find out more. (1) Popple RA, Brown MH, Thomas EM et al. Transition From Manual to Automated Planning and Delivery of Volumetric Modulated Arc Therapy Stereotactic Radiosurgery: Clinical, Dosimetric, and Quality Assurance Results, Practical Radiation Oncology, 11:2, March 2021, pages E163-E171.

Click to Learn More

March 2022

World-Class SRS in a Japanese Bullet Train Station – Setting New Standards in Patient Access and Convenience

ZAP Surgical recently announced installation of its pioneering vault-free, cobalt-free Gyroscopic Radiosurgery platform at the newly redeveloped Utsunomiya bullet train station in Japan’s Tochigi Prefecture. The new installation brings advanced radiosurgery to an entirely new, more cost-effective setting outside of the large urban hospital.

Click to Learn More

February 2022

ZAP Surgical Inspires Expansion of Novel Non-Invasive Brain Tumor Procedures to Unique Suburban Settings

A sea change in how and where world-class radiosurgery is delivered. Large academic hospitals are expanding SRS to new, lower cost locations: suburban and rural community hospitals, as well as innovative outpatient settings (e.g. a bullet train station in Japan). Read the full article and interesting community discussions.

Click to Learn More

New ZAP-X Publication from Barrow Neurological Institute

An informative ZAP-X case series from Barrow Neurological Insitute. 59 patients spanning a comprehensive mix of meningioma, metastases, glioma, schwannoma, and pituitary tumor SRS cases.

Click To Learn More

RefleXion Introduces New Scientific Advisory Board

“Since cancer care is multidisciplinary, it made sense to establish a scientific advisory board with deep and broad knowledge across multiple specialties,” said Sean Shirvani, MD, RefleXion’s chief medical officer. Meet the medical experts on our new scientific advisory board.

Meet the New Scientific Advisory Board

ViewRay Receives 510(k) Clearance on Next Generation of MRIdian MRI-Guided Radiation Therapy Features

MRIdian A3i and Brain Treatment Package Enhance On-Table Adaptive Workflow and Expand Clinical Utility

Click To Learn More

January 2022

ViewRay Receives 510(k) Clearance on Next Generation of MRIdian MRI-Guided Radiation Therapy Features

ViewRay, Inc. (NASDAQ: VRAY) announced that the company received FDA 510(k) clearance for its next generation of MRI-guided radiation therapy features, focused on enhancing on-table adaptive workflow and expanding clinical utility. MRIdian A3i includes a suite of new features to streamline on-table adaptive workflow and provide the potential to reduce treatment times, along with a new brain treatment package expanding clinical utility into cranial stereotactic radiosurgery (SRS) and stereotactic radiation therapy (SRT).

Click To Learn More

World Class Dosimetry, Remarkable Throughput

Congratulations to Dr. Alexander Muacevic and the team at European Radiosurgery Center Munich for having recently treated 50 SRS patients with the ZAP-X Gyroscopic Radiosurgery platform in just a few short months. A beautiful center delivering world-class medicine.

Click to Learn More

ZAP-X Planning Study: Temporoparietal AVM

See how the vault-free, cobalt-free ZAP-X® Gyroscopic Radiosurgery® platform delivers an exceptionally low V12 to normal brain tissue with an extraordinarily sharp dose gradient.

Click To Request the Study

RefleXion X1 Headed to UPMC

Another RefleXion X1 recently left the factory heading to University of Pittsburgh Medical Center. They will be among the first to deliver biology-guided radiotherapy (BgRT)* utilizing the cancer itself to guide radiation delivery, even in tumors that are moving. The technology uses PET to guide personalized radiotherapy.

*The RefleXion™ X1 is cleared for SBRT/SRS/IMRT treatments. BgRT is limited by U.S. law to Investigational use.

Click To Learn More

RefleXion Founder Awarded 2021 Engineering Alumni Achievement Medal

Sam Mazin, founder and CTO of RefleXion, is the winner of the 2021 Faculty of Engineering Alumni Achievement Medal from his alma mater the University of Waterloo. This award honors alumni who have distinguished themselves through professional achievements, community service or academic excellence.

Click To Learn More

New Podcast! RefleXion and HealthMyne Partner to Advance Personalized Care

Rose Higgins, chief executive officer at HealthMyne, Inc., sits down with Sam to discuss the role radiomics is playing in cancer care. Our biology-guided radiotherapy will generate a plethora of new data that will one day become part of the data fabric to help us understand what is happening at both the molecular and biological level. This podcast dives into how radiomics can provide insights to better inform treatment decisions and what the future may hold.

Click To Listen

ZAP Surgical Appoints Industry Veterans to Lead Chinese Market Expansion

ZAP Kicks Off Chinese Market Expansion. Chinese Trials Concluded, NMPA Clearance Expected Soon.

Click To Learn More

The First ZAP-X in Colorado, Installation Underway!

Congratulations to the team at Neurosurgery One and Littleton Adventist Hospital.

Click To Learn More

ViewRay Announces MRIdian MR-Guided Radiation Therapy Surpasses 2,300 Pancreatic Cancer Patients Treated Worldwide

With 46 Centers in 16 Countries, Clinical Teams are Changing the Paradigm for Pancreatic Cancer with MRIdian.

Click to Learn More

Accuray CyberKnife® Robotic Radiotherapy Platform Expands Range of Neurological Indications That Can Be Effectively Treated With Stereotactic Radiosurgery

7,000 Patient Single Institution Analysis Shows Safety, Versatility and Increasing Use of the Advanced Radiotherapy Platform Over a 20-Year Timeframe.

Click to Learn More

RefleXion Receives Breakthrough Device Designation for Lung Cancer Treatment

The U.S. Food and Drug Administration (FDA) has granted RefleXion Breakthrough Device Designation for its biology-guided radiotherapy* (BgRT) for use in treating lung tumors. The breakthrough potential of BgRT lies in its ability to detect and then immediately treat moving tumors. It is the first and only technology to use injected radiotracers to produce active signals, called emissions, from each tumor to guide treatment delivery.

Click to Learn More

November 2021

ZAP Surgical to Bring Next-Gen Non-Invasive Brain Tumor Treatment to the American Hospital of Paris Group

Centre de Cancérologie de la Porte de Saint-Cloud is to become the first in France to offer ZAP-X Gyroscopic Radiosurgery.

Click To Learn More

Accuray CyberKnife Robotic Radiotherapy Platform Could Significantly Improve Survival in Early-Stage Breast Cancer Patients

Accuray Incorporated announced that a study published in Frontiers in Oncology found early-stage breast cancer patients could experience significant improvements in survival if treated with accelerated partial breast irradiation (APBI) delivered using the Accuray CyberKnife robotic radiotherapy platform.

Click to Learn More

New Outcomes Data Demonstrating Prolonged Survival for Inoperable Pancreatic Cancer Patients Presented at Leading Radiation Oncology Meeting

Findings Show Median Overall Survival Of 26 Months for Patients Receiving Ablative Doses with MRIdian MRI-Guided Radiation Therapy.

Click To Learn More

October 2021

Coming Soon: The First ZAP-X in Spain

The new Institute of Advanced Radiosurgery at the Viamed Virgen de la Paloma Hospital in Madrid to soon offer the next generation of stereotactic radiosurgery.

Click To Learn More

Academic Congresses Return!

ZAP is extremely proud to sponsor the 2021 Congress of Neurological Surgeons (CNS) meeting, Oct 16-20, in Austin, TX.

Stop by booth #1749 to experience ZAP-X in Augmented Reality - and see for yourself how ZAP is boldly going where no SRS system has gone before.

Click To Learn More

ZAP-X Complex Meningioma Treatment Planning Study

See how the vault-free, cobalt-free ZAP-X® Gyroscopic Radiosurgery® platform delivers an exceptionally sharp dose gradient with remarkably low dose to the cochlea and healthy brain.

Click To Request the Study

ViewRay Announces 510(k) Pending Status of the Newest Generation of MRIdian Innovations

New suite of workflow and clinical features to be highlighted at upcoming ASTRO 2021 conference.

Click to Learn More

September 2021

Trigeminal Neuralgia Treatment Planning Study

Trigeminal neuralgia is often considered the most demanding of all SRS procedures. Combined with rapid planning and delivery times, see how the ZAP-X delivers an exceptionally sharp dose gradient with a remarkably low dose to the brainstem.

Request the Study

UAB Adds Personalized Touch to Cancer Treatment with Adaptive Radiation

Story by Bob Shepard

They are calling it radiation oncology’s contribution to personalized medicine. Adaptive radiation — called by some the holy grail of radiation therapy — has come to the University of Alabama at Birmingham O’Neal Comprehensive Cancer Center in the form of the newest radiation delivering tool, a linear accelerator system called Ethos from Varian.

Read More

August 2021

First Patients Treated in Munich

Dr. Alexander Muacevic and the European Radiosurgery Center Munich had a productive first week of clinical SRS treatments. 2 meningiomas, 2 acoustic neuromas, and a multiple brain mets patient in the first 2 days. Remarkable!

Read More

ViewRay Announces First Patient Enrolled in Stereotactic MRI-guided On-table Adaptive Radiation Therapy (SMART) Trial for Locally Advanced Pancreatic Cancer

Study to Explore Clinical Benefits of Precise, High Dose Radiation Therapy Enabled by MRIdian's MR-guidance Combined with Daily On-table Adaptation in Pancreatic Cancer.

Read More

July 2021

SRS Investment 'Future Proofed' with ZAP-X

With continuing pressure from the IAEA to abolish the use of radioactive sources, the cobalt-free ZAP-X at the Swiss Neuro Radiosurgery Center (SNRC) has ensured the long-term viability of their SRS investment. SNRC initiated first patient treatments on June 16, 2021.

Read More

Renowned SRS Provider Breaks Ground with Vault-Free ZAP-X Installation

Considered among the most accomplished radiosurgery providers in the world, neurosurgeon Alex Muacevic and the European CyberKnife Center in Munich recently commenced installation of its ZAP-X Gyroscopic Radiosurgery platform.

Read More

Mitigating the Risks of Cognitive Deficit

With regional recurrence rates post-SRS ranging from 67% to 76%, minimal mean whole brain dose is a critical enabler for future potential radiosurgical re-treatment. A recent multiple mets ZAP-X study demonstrated exceptionally low mean whole brain dose and 100% target coverage using 0 mm PTV margins - not to mention, remarkably rapid planning and delivery times.

Read More

UPMC Hillman Cancer Center Among First in Country to Offer Radiotherapy That Lets Tumors Guide Treatment

UPMC Hillman Cancer Center will be the first cancer center in the eastern United States, and one of just a handful in the country, to offer the most advanced radiotherapy system for treating patients.

The RefleXion™X1 is the world’s first biology-guided radiotherapy (BgRT) machine that’s expected to improve treatment and expand options for patients with metastatic disease, where few treatments are currently available.

Read More

Elekta Harmony Receives FDA Approval

Elekta received FDA clearance for a new linear accelerator called Elekta Harmony. Elekta Harmony is built for productivity, versatility and precision and features the new FastTrack workflow experience.

Read More